| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $83.8M | +22.0% |
| Cost of Revenue | $21.8M | +21.6% |
| Gross Profit | $62.0M | +22.2% |
| R&D Expense | $17.6M | -2.8% |
| SG&A Expense | $102.1M | +8.0% |
| Operating Income | -$57.7M | +6.8% |
| Pre-tax Income | -$55.9M | +7.3% |
| Income Tax | $500K | -12.4% |
| Net Income | -$56.4M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $70.9M | -15.1% |
| Accounts Receivable | $13.1M | +8.4% |
| Inventory | $16.9M | +1.0% |
| Current Assets | $136.2M | -9.4% |
| Total Assets | $162.8M | -8.4% |
| Current Liabilities | $24.4M | +5.5% |
| Long-term Debt | $37.2M | -0.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$31.5M | +16.1% |
| Capital Expenditures | $1.4M | +79.3% |
| Investing Cash Flow | $17.5M | +970.8% |
| Financing Cash Flow | $1.4M | -93.6% |
| Free Cash Flow | -$33.0M | +14.1% |
| +7.3% |
| EPS (Basic) | -$1.44 | +10.0% |
| EPS (Diluted) | -$1.44 | +10.0% |
| Total Liabilities |
| $77.0M |
| +29.6% |
| Stockholders' Equity | $85.8M | -27.5% |